logo

MXCT

Maxcyte·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

MXCT fundamentals

Maxcyte (MXCT) released its earnings on Nov 5, 2025: revenue was 6.83M (YoY -16.72%), missed estimates; EPS was -0.12 (YoY -9.09%), missed estimates.
Revenue / YoY
6.83M
-16.72%
EPS / YoY
-0.12
-9.09%
Report date
Nov 5, 2025
Earnings Call
4:30 PM on Nov 5, 2025
Meeting link.
EPS
Revenue

Revenue & Expenses

MXCT has released its 2025 Q3 earnings report, with revenue of 6.83M, reflecting a YoY change of -16.35%, and net profit of -12.42M, showing a YoY change of -7.43%. The Sankey diagram below clearly presents MXCT's revenue sources and cost distribution.

Key Indicators

Maxcyte (MXCT) key financial stats and ratios, covering profitability, financial health, and leverage.
Maxcyte (MXCT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Maxcyte (MXCT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Maxcyte (MXCT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Maxcyte (MXCT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Maxcyte (MXCT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield